Innoblative announces first-in-human use of its Novel Electrosurgical Device for Breast Cancer Treatment

Rubriques :

CHICAGO, USA – Innoblative Designs, Inc., a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has initiated its first-in-human clinical experience, successfully treating a 64-year-old patient with stage II luminal a breast cancer. The initial lumpectomy case was performed by Dr Cem Yilmaz, Breast Surgeon and Founding Director of […]

Ghanaian U.S Base Medical Doctor Has Developed Robotic That Can Commence Surgery Without Using Human Arms

akelicious.net - 25/Aug 08:46

A renowned Ghanaian-born, U.S.-based medical doctor, Dr. John de-Graft Johnson, has developed a groundbreaking robotic surgery device that performs...

Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in Women with Breast Cancer Receiving Adjuvant Endocrine Therapy

drugs.com - 28/Aug 00:08

TOKYO, Aug. 27, 2024. Astellas Pharma Inc. (today announced dosing of the first patient in the HIGHLIGHT 1 Phase 3 pivotal study for fezolinetant, an...

Rubriques :

Innoblative announces first-in-human use of its Novel Electrosurgical Device for Breast Cancer Treatment

Articles similaires

Ghanaian U.S Base Medical Doctor Has Developed Robotic That Can Commence Surgery Without Using Human Arms

Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in Women with Breast Cancer Receiving Adjuvant Endocrine Therapy

Elle McPherson reveals she had breast cancer

Elle McPherson reveals she had breast cancer

Elle McPherson reveals she had breast cancer

RBW Consulting: Head of Discovery and Preclinical Research

New treatment could shrink tumors in pancreatic cancer

Almost Half Of FDA-Approved AI Medical Devices Are Not Trained On Real Patient Data

SDC Capture Revolutionizes Clinical Trials with new BYOD ePRO Solution

Izotropic to launch Izoview for breast cancer diagnostics

Les derniers communiqués